Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-573-5 | CAS number: 3147-75-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In the key study, 0 out of 20 guinea pigs gave positive results after challenge exposures with the test article.Therefore, the test article is considered not sensitizing after skin contact (reliability score: 1).
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study, guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- When this study was performed, the LLNA did yet exist as an OECD guideline.
- Specific details on test material used for the study:
- - Name of test substance (as cited in study report): Tinuvin 329
- Analytical purity: >99%
- Batch No.: EN 171744.92
- Physical state: solid
- Storage conditions: room temperature
- Validity: November 1993 - Species:
- guinea pig
- Strain:
- other: Pirbright White Strain (Tif: DHP)
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: CIBA-GEIGY Ltd., Animal Production, 4332 Stein, Switzerland
- Weight at study initiation (range): 351 g - 433 g
- Housing: individually in Makrolon cages (type 3)
- Diet: standard guinea pig pellets (NAFAG No. 845, Gosau SG); ad libitum
- Water: ad libitum
- Acclimation period: 5-6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12/12 - Route:
- intradermal and epicutaneous
- Vehicle:
- other: oleum arachidis (intradermal) and vaseline (epidermal)
- Concentration / amount:
- Induction, intradermal: 5% in oleum arachidis
Induction, epidermal: 30% in vaseline
Challenge, epidermal: 10% in vaseline - Route:
- epicutaneous, occlusive
- Vehicle:
- other: oleum arachidis (intradermal) and vaseline (epidermal)
- Concentration / amount:
- Induction, intradermal: 5% in oleum arachidis
Induction, epidermal: 30% in vaseline
Challenge, epidermal: 10% in vaseline - No. of animals per dose:
- - Test group: 10 males and 10 females
- Control group: 5 males and 5 females - Details on study design:
- RANGE FINDING TESTS:
To identify irritant concentrations of the test substance a preliminary study was performed to select suitable, non-irritant concetration for the main study.
- Intradermal: 1% and 5% were tested and both were well tolerated
- Epidermal: 1, 5, 10 and 30% were tested and none of them induced erythema reactions
MAIN STUDY
A. INDUCTION EXPOSURE
Intradermal:
- No. of exposures: one intradermal application (3 pairs of intradermal injections (each 0.1 mL) were made simultaneously into the shaved neck of the guinea pigs)
- Test groups: intradermal: 1) adjuvant/saline mixture 1:1 (v/v), 2) test article in oleum arachidis (w/v), 3) test article in the adjuvant saline mixture (w/v);
- Control group: same treatment as test group only with adjuvant and vehicle
- Site: neck region
- Concentrations: intradermal: 5%
Epidermal:
- Test group: epidermal: closed patch exposure over the injection sites (test substance in vaseline, 2 x 4 cm², ca. 0.4 g paste per patch)
- Control groups: same treatment as test group only with adjuvant and vehicle
- Concentrations: 30% in vaseline
- Duration of exposure: 48 h
- Schedule: one week after intradermal induction (week 2)
week 3 and 4: no treatment
B. CHALLENGE EXPOSURE
- No. of exposures:1
- Day of challenge: day 29 (4 weeks after study initiation)
- Exposure period:24 h
- Test groups: the animals were tested with the test article in vaseline and the vehicle alone (patch 2 x 2 cm², 0.2 g paste per patch, occluded administration).
- Control group: The control group was treated with the vehicle as well as with the test article to check the maximum subirritant concentration of the test article in adjuvant treated animals.
- Site: flank
- Concentrations: 10%
- Evaluation (hr after challenge): 24 h and 48 h after removing the dressings, the challenge reactions were graded according to the Draize scoring scale.
OTHER:
The sesitivity of the strain is checked every six months with a known sensitiser, such as 2,4-dinitrochlorobenzene, para-phenylene-diamine or potasium-dichromate.
The body weight was recorded at start and end of the test. - Positive control substance(s):
- yes
- Remarks:
- 2,4-dinitrochlorobenzene, para-phenylene-diamine or potassium-dichromate.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 10%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no effects
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no effects.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no effects
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 0%. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no effects.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 10%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no effects
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no effects.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no effects
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 0%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no effects.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no effects
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no effects.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no effects
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0%. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no effects.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 10%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no effects
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: no effects.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no effects
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 0%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no effects.
- Interpretation of results:
- GHS criteria not met
Reference
Mean body weight (study initiation; study termination):
- Test group: males: 382 g; 602 g; females: 375 g; 564 g
- Control group: males: 383 g; 629 g; females: 377 g; 569 g
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In a dermal sensitisation study with the test substance (> 99% pure) in oleum arachidis or vaseline, Pirbright White Strain (Tif: DHP) guinea pigs (10 males and 10 females) were tested using the method of the guinea pig maximisation test according to the OECD TG 406. Intradermal and epicutaneous induction (occlusive, 48 h) was performed with 5% (in oleum arachidis) and 30% (in vaseline) of the test substance, respectively. Epicutaneous challenge exposure (occlusive, 24 h) was performed with 10% (in vaseline) of the test substance. 2,4-dinitrochlorobenzene and para-phenylene-diamine or potassium-dichromate were used as positive control substances. Evaluation of the skin reactions were performed 24 and 48 hours after challenge according to the Draize method. No deaths occurred and no clinical signs of toxicity or irritation were seen in any animal. In this study, the test substance is not a dermal sensitizer. 0/20 animals had positive skin responses at either observation time points (24 and 48 h) after end of challenge exposure.
The study is suitable for assessment of sensitizing potential as it was performed according to OECD 406 and GLP standards.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Dangerous substance Directive (67/548/EEC)
The available experimental test data are considered reliable and suitable for the purpose of classification. Based on the criteria for classification of Directive 67/548/EEC, as amended for the 28th time in Directive 2001/59/EC, classification as a skin sensitizer is not warranted.
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for the purpose of classification. Based on the criteria laid down in Regulation (EC) No. 1272/2008, as amended for the fifth time in Directive EC 944/2013, classification as a skin sensitizer is not warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.